Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 04; 12(4):e007133.
View in:
PubMed
subject areas
Aged
Aged
Anemia
Anemia
Biomarkers
Biomarkers
Coronary Artery Disease
Coronary Artery Disease
Drug Administration Schedule
Drug Administration Schedule
Drug Therapy, Combination
Drug Therapy, Combination
Female
Female
Hemoglobins
Hemoglobins
Hemorrhage
Hemorrhage
Humans
Humans
Male
Male
Medication Adherence
Medication Adherence
Middle Aged
Middle Aged
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prospective Studies
Prospective Studies
Registries
Registries
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
authors with profiles
Usman Baber